Your browser doesn't support javascript.
loading
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
Wilson, Andrew M; Clark, Allan B; Cahn, Tony; Chilvers, Edwin R; Fraser, William; Hammond, Matthew; Livermore, David M; Maher, Toby M; Parfrey, Helen; Swart, Ann Marie; Stirling, Susan; Thickett, David R; Whyte, Moira.
Afiliación
  • Wilson AM; Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, Norfolk, United Kingdom.
  • Clark AB; Department of Respiratory Medicine, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, Norfolk, United Kingdom.
  • Cahn T; Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, Norfolk, United Kingdom.
  • Chilvers ER; Department of Respiratory Medicine, Bedford Hospitals NHS Trust, South Wing, Bedford, United Kingdom.
  • Fraser W; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Hammond M; Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, Norfolk, United Kingdom.
  • Livermore DM; Department of Endocrinology and Clinical Biochemistry, Norfolk and Norwich University Hospital NHS Foundation Trust, Colney Lane, Norwich, Norfolk, United Kingdom.
  • Maher TM; Norwich Clinical Trials Unit, University of East Anglia, Norwich Research Park, Norwich, Norfolk, United Kingdom.
  • Parfrey H; Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, Norfolk, United Kingdom.
  • Swart AM; Department of Endocrinology and Clinical Biochemistry, Norfolk and Norwich University Hospital NHS Foundation Trust, Colney Lane, Norwich, Norfolk, United Kingdom.
  • Stirling S; Hastings Centre for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
  • Thickett DR; NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, London, United Kingdom.
  • Whyte M; Royal Papworth Hospital NHS Foundation Trust, Papworth Road, Cambridge Biomedical Campus, Cambridge, United Kingdom.
JAMA ; 324(22): 2282-2291, 2020 12 08.
Article en En | MEDLINE | ID: mdl-33289822

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Combinación Trimetoprim y Sulfametoxazol / Fibrosis Pulmonar Idiopática Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: JAMA Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Combinación Trimetoprim y Sulfametoxazol / Fibrosis Pulmonar Idiopática Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: JAMA Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido